{"url":"https://nivawealth.com/firms/orbimed-advisors-118608","iapdUrl":"https://adviserinfo.sec.gov/firm/summary/118608","regulatoryAum":20607970000,"crd":"118608","secFileNumber":"801-61046","legalName":"Orbimed Advisors LLC","displayName":"Orbimed Advisors","website":"http://www.orbimed.com","linkedinUrl":"https://www.linkedin.com/company/orbimed-advisors/","founded":null,"organization":"Delaware limited liability company","fiscalYearEnd":"December","headquarters":{"street":"601 Lexington Avenue, 54th Floor","city":"New York","state":"NY","stateName":"New York","country":"United States","postalCode":"10022"},"tradeNames":["Orbimed Capital LLC"],"registration":{"secApproved":"22 April 2002","noticeFilings":null,"latestNoticeFiling":null},"staff":{"employees":118,"advisory":86,"brokerDealerReps":0,"insuranceAgents":0,"promoters":2},"aum":{"discretionary":20607970000,"discretionaryAccounts":32,"nonDiscretionary":0,"nonDiscretionaryAccounts":0,"wrapProgram":null,"nonUsClientsPct":63,"nonAumClients":0},"clientTypes":[{"label":"Pooled investment vehicles","clients":32,"regulatoryAum":20607970000}],"fees":[],"feeNotes":[],"feePrograms":[],"brochureCoverage":{"scope":"known_documents","status":"not_processed","checkedAt":null,"documents":[]},"custodians":[],"custodyNote":"Orbimed Advisors has custody of $18.28B for 30 clients.","otherCustodians":[],"leadership":[{"name":"Sam Block III","title":"Chief Financial Officer","crd":"7087692"},{"name":"Douglas Coon","title":"Chief Compliance Officer","crd":"5060118"},{"name":"Mona Ashiya","title":"Member","crd":"4947842"},{"name":"David Bonita","title":"Member","crd":"2978821"},{"name":"Alexander Cooper","title":"General Counsel","crd":"5888312"},{"name":"Carl Gordon","title":"Member","crd":"1901172"},{"name":"Geoffrey Hsu","title":"Member","crd":"5777628"},{"name":"William Neild","title":"Member","crd":"2277967"},{"name":"Matthew Rizzo","title":"Member","crd":"7489316"},{"name":"Charles Stevens","title":"Member","crd":"2909422"},{"name":"Peter Thompson","title":"Member","crd":"7489318"}],"ownership":[{"label":"Carl Gordon","detail":"Member in the 25% to 50% ownership band and a control person, since January 1998."},{"label":"William Neild","detail":"Member in the 10% to 25% ownership band and a control person, since January 2007."},{"label":"Geoffrey Hsu","detail":"Member in the 10% to 25% ownership band and a control person, since January 2010."},{"label":"Charles Stevens","detail":"Member in the 5% to 10% ownership band and a control person, since April 2019."},{"label":"David Bonita","detail":"Member in the 5% to 10% ownership band and a control person, since January 2020."},{"label":"Matthew Rizzo","detail":"Member in the 5% to 10% ownership band and a control person, since January 2022."},{"label":"Peter Thompson","detail":"Member in the 5% to 10% ownership band and a control person, since January 2022."},{"label":"Mona Ashiya","detail":"Member in the 5% to 10% ownership band and a control person, since July 2025."}],"branchOffices":null,"filedOffices":{"otherThanPrincipal":6,"privateResidences":0},"listedOfficeAddresses":2,"officesByState":[{"state":"California","offices":1,"addresses":[{"street":"611 Gateway Boulevard","city":"South San Francisco"}]},{"state":"New York","offices":1,"addresses":[{"street":"601 Lexington Avenue, 54th Floor","city":"New York","headquarters":true}]}],"advFacts":{"source":{"file":"ia100226.zip","asOf":"2 October 2026"},"telephone":"212-739-6400","stateRegisteredReps":0,"otherAdviserReps":0,"compensation":["A percentage of assets under management","Performance-based fees"],"activities":["Portfolio management for pooled investment vehicles (other than investment companies)"],"financialPlanningClients":null,"assetMix":[],"privateFunds":24},"sources":{"adv1FilingDate":"18 August 2026","adv1Url":"https://reports.adviserinfo.sec.gov/reports/ADV/118608/PDF/118608.pdf","brochureDate":null,"brochureUrl":null,"iapdCompiledDate":null,"retrievedDate":"15 October 2026","retrievedOn":"2026-10-15","adv1Pages":{},"brochurePages":{}},"otherBusiness":[],"faq":[{"question":"How many clients does Orbimed Advisors have?","answer":"Orbimed Advisors has 32 clients and manages $20.6 billion for them, as of August 2026.","source":"Form ADV Part 1A, Items 5.D and 5.F, filed 18 August 2026","sourceRef":{"doc":"adv1","section":"employees"}},{"question":"What services does Orbimed Advisors offer?","answer":"Orbimed Advisors provides portfolio management for pooled vehicles.","source":"Form ADV Part 1A, Item 5.G, from the SEC's 2 October 2026 data file","sourceRef":{"doc":"adv1","section":"employees"}},{"question":"How many financial advisors does Orbimed Advisors have?","answer":"Orbimed Advisors has 0 investment adviser representatives registered with state securities authorities, out of 118 employees, and 86 perform investment advisory functions. None are registered representatives of a broker-dealer or licensed insurance agents.","source":"Form ADV Part 1A, Items 5.A and 5.B, from the SEC's 2 October 2026 data file","sourceRef":{"doc":"adv1","section":"employees"}},{"question":"Who owns Orbimed Advisors?","answer":"Orbimed Advisors’ direct owners are Carl Gordon, William Neild, Geoffrey Hsu, Charles Stevens, David Bonita, Matthew Rizzo, Peter Thompson and Mona Ashiya, each holding 50% or less.","source":"Form ADV Part 1A, Schedules A and B, filed 18 August 2026","sourceRef":{"doc":"adv1","section":"scheduleA"}},{"question":"How does Orbimed Advisors get paid?","answer":"Orbimed Advisors is paid through a percentage of assets under management and performance-based fees. Its Form ADV lists no commissions among how it is paid.","source":"Form ADV Part 1A, Item 5.E, from the SEC's 2 October 2026 data file","sourceRef":{"doc":"adv1","section":"employees"}}],"holdings":{"url":"https://nivawealth.com/firms/orbimed-advisors-118608/holdings","form":"13F-HR","periodOfReport":"2026-06-30","filedOn":"2026-08-14","filingIndexUrl":"https://www.sec.gov/Archives/edgar/data/1055951/000117266126003740/0001172661-26-003740-index.html","totalValue":5396779685,"positionCount":129,"top10Share":0.42095499994456415,"top10":[{"issuer":"EDGEWISE THERAPEUTICS INC","titleOfClass":"COM","cusip":"28036F105","value":630516330,"shares":15518492,"shareType":"SH","priorValue":488832498,"priorShares":15518492},{"issuer":"ENLIVEN THERAPEUTICS INC","titleOfClass":"COM","cusip":"29337E102","value":343914074,"shares":6776632,"shareType":"SH","priorValue":312013890,"priorShares":7959538},{"issuer":"ELI LILLY & CO","titleOfClass":"COM","cusip":"532457108","value":309332997,"shares":257900,"shareType":"SH","priorValue":217801536,"priorShares":236800},{"issuer":"MBX BIOSCIENCES INC","titleOfClass":"COM","cusip":"55287L101","value":189266227,"shares":3428736,"shareType":"SH","priorValue":108590927,"priorShares":3637887},{"issuer":"SINOVAC BIOTECH LTD","titleOfClass":"SHS","cusip":"P8696W104","value":184466170,"shares":2718735,"shareType":"SH","priorValue":184466170,"priorShares":2718735},{"issuer":"ASTRAZENECA PLC","titleOfClass":"ORD","cusip":"G0593M107","value":171079502,"shares":915700,"shareType":"SH","priorValue":132176844,"priorShares":670200},{"issuer":"STRUCTURE THERAPEUTICS INC","titleOfClass":"SPONSORED ADS","cusip":"86366E106","value":118578498,"shares":2209400,"shareType":"SH","priorValue":71114425,"priorShares":1475403},{"issuer":"SIONNA THERAPEUTICS INC","titleOfClass":"COM","cusip":"829401108","value":112433029,"shares":2555877,"shareType":"SH","priorValue":141545843,"priorShares":3530702},{"issuer":"CORVUS PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"221015100","value":107045190,"shares":7165006,"shareType":"SH","priorValue":104824038,"priorShares":7165006},{"issuer":"ARRIVENT BIOPHARMA INC","titleOfClass":"COM","cusip":"04272N102","value":105169375,"shares":3027328,"shareType":"SH","priorValue":69840457,"priorShares":3027328}],"positionsListed":129,"positions":[{"issuer":"EDGEWISE THERAPEUTICS INC","titleOfClass":"COM","cusip":"28036F105","value":630516330,"shares":15518492,"shareType":"SH","priorValue":488832498,"priorShares":15518492},{"issuer":"ENLIVEN THERAPEUTICS INC","titleOfClass":"COM","cusip":"29337E102","value":343914074,"shares":6776632,"shareType":"SH","priorValue":312013890,"priorShares":7959538},{"issuer":"ELI LILLY & CO","titleOfClass":"COM","cusip":"532457108","value":309332997,"shares":257900,"shareType":"SH","priorValue":217801536,"priorShares":236800},{"issuer":"MBX BIOSCIENCES INC","titleOfClass":"COM","cusip":"55287L101","value":189266227,"shares":3428736,"shareType":"SH","priorValue":108590927,"priorShares":3637887},{"issuer":"SINOVAC BIOTECH LTD","titleOfClass":"SHS","cusip":"P8696W104","value":184466170,"shares":2718735,"shareType":"SH","priorValue":184466170,"priorShares":2718735},{"issuer":"ASTRAZENECA PLC","titleOfClass":"ORD","cusip":"G0593M107","value":171079502,"shares":915700,"shareType":"SH","priorValue":132176844,"priorShares":670200},{"issuer":"STRUCTURE THERAPEUTICS INC","titleOfClass":"SPONSORED ADS","cusip":"86366E106","value":118578498,"shares":2209400,"shareType":"SH","priorValue":71114425,"priorShares":1475403},{"issuer":"SIONNA THERAPEUTICS INC","titleOfClass":"COM","cusip":"829401108","value":112433029,"shares":2555877,"shareType":"SH","priorValue":141545843,"priorShares":3530702},{"issuer":"CORVUS PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"221015100","value":107045190,"shares":7165006,"shareType":"SH","priorValue":104824038,"priorShares":7165006},{"issuer":"ARRIVENT BIOPHARMA INC","titleOfClass":"COM","cusip":"04272N102","value":105169375,"shares":3027328,"shareType":"SH","priorValue":69840457,"priorShares":3027328},{"issuer":"GUARDANT HEALTH INC","titleOfClass":"COM","cusip":"40131M109","value":87572511,"shares":583700,"shareType":"SH","priorValue":40199424,"priorShares":435200},{"issuer":"ARGENX SE","titleOfClass":"SPONSORED ADR","cusip":"04016X101","value":86171278,"shares":92880,"shareType":"SH","priorValue":99971225,"priorShares":136900},{"issuer":"MERCK & CO INC","titleOfClass":"COM","cusip":"58933Y105","value":85246900,"shares":663400,"shareType":"SH","priorValue":79800386,"priorShares":663400},{"issuer":"UNIQURE NV","titleOfClass":"SHS","cusip":"N90064101","value":83252805,"shares":1807486,"shareType":"SH","priorValue":34926036,"priorShares":2136149},{"issuer":"PRAXIS PRECISION MEDICINES I","titleOfClass":"COM NEW","cusip":"74006W207","value":77035179,"shares":230100,"shareType":"SH","priorValue":55577775,"priorShares":172500},{"issuer":"EDWARDS LIFESCIENCES CORP","titleOfClass":"COM","cusip":"28176E108","value":75525054,"shares":834900,"shareType":"SH","priorValue":98546448,"priorShares":1230600},{"issuer":"PRELUDE THERAPEUTICS INC","titleOfClass":"COM","cusip":"74065P101","value":73151963,"shares":13724571,"shareType":"SH","priorValue":37309656,"priorShares":10909256},{"issuer":"ABIVAX SA","titleOfClass":"SPONSORED ADS","cusip":"00370M103","value":72829522,"shares":546522,"shareType":"SH","priorValue":51855695,"priorShares":465700},{"issuer":"DYNE THERAPEUTICS INC","titleOfClass":"COM","cusip":"26818M108","value":71864542,"shares":3235684,"shareType":"SH","priorValue":52901237,"priorShares":2917884},{"issuer":"NATERA INC","titleOfClass":"COM","cusip":"632307104","value":71119900,"shares":262000,"shareType":"SH","priorValue":52397380,"priorShares":262000},{"issuer":"CG ONCOLOGY INC","titleOfClass":"COM","cusip":"156944100","value":69117440,"shares":972800,"shareType":"SH","priorValue":64178711,"priorShares":948267},{"issuer":"UNITEDHEALTH GROUP INC","titleOfClass":"COM","cusip":"91324P102","value":66957993,"shares":161100,"shareType":"SH"},{"issuer":"ARS PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"82835W108","value":66390965,"shares":8288510,"shareType":"SH","priorValue":66556735,"priorShares":8288510},{"issuer":"ASCENDIS PHARMA A/S","titleOfClass":"ORD SHS","cusip":"K08588103","value":65201304,"shares":244456,"shareType":"SH"},{"issuer":"HUMANA INC","titleOfClass":"COM","cusip":"444859102","value":65183802,"shares":164100,"shareType":"SH"},{"issuer":"COGENT BIOSCIENCES INC","titleOfClass":"COM","cusip":"19240Q201","value":65066310,"shares":1681300,"shareType":"SH","priorValue":12397629,"priorShares":322100},{"issuer":"BOSTON SCIENTIFIC CORP","titleOfClass":"COM","cusip":"101137107","value":63302976,"shares":1483200,"shareType":"SH","priorValue":149476775,"priorShares":2382100},{"issuer":"INTUITIVE SURGICAL INC","titleOfClass":"COM NEW","cusip":"46120E602","value":62793672,"shares":157900,"shareType":"SH","priorValue":96208613,"priorShares":208700},{"issuer":"MINERALYS THERAPEUTICS INC","titleOfClass":"COM","cusip":"603170101","value":56935894,"shares":2110300,"shareType":"SH","priorValue":55613061,"priorShares":2052900},{"issuer":"ODYSSEY THERAPEUTICS INC","titleOfClass":"COMMON STOCK","cusip":"67613T104","value":56152415,"shares":3001198,"shareType":"SH"},{"issuer":"XENON PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"98420N105","value":53869550,"shares":892471,"shareType":"SH","priorValue":61637314,"priorShares":1059971},{"issuer":"ARCUTIS BIOTHERAPEUTICS INC","titleOfClass":"COM","cusip":"03969K108","value":53541240,"shares":2042000,"shareType":"SH"},{"issuer":"BRISTOL-MYERS SQUIBB CO","titleOfClass":"COM","cusip":"110122108","value":53298500,"shares":925000,"shareType":"SH","priorValue":56101250,"priorShares":925000},{"issuer":"Q32 BIO INC","titleOfClass":"COM","cusip":"746964105","value":52590554,"shares":4127987,"shareType":"SH","priorValue":14464177,"priorShares":2252987},{"issuer":"STRYKER CORPORATION","titleOfClass":"COM","cusip":"863667101","value":50091044,"shares":159100,"shareType":"SH","priorValue":59967675,"priorShares":182500},{"issuer":"CARIS LIFE SCIENCES INC","titleOfClass":"COM","cusip":"142152107","value":50017372,"shares":2806811,"shareType":"SH","priorValue":50185781,"priorShares":2806811},{"issuer":"SPDR SERIES TRUST","titleOfClass":"ST STR SP BIOT","cusip":"78464A870","value":47475000,"shares":300000,"shareType":"SH","putCall":"Put"},{"issuer":"THERMO FISHER SCIENTIFIC INC","titleOfClass":"COM","cusip":"883556102","value":45473352,"shares":90700,"shareType":"SH","priorValue":22856145,"priorShares":46500},{"issuer":"PALVELLA THERAPEUTICS INC NE","titleOfClass":"COM","cusip":"697947109","value":44678455,"shares":292360,"shareType":"SH","priorValue":16777890,"priorShares":134600},{"issuer":"ELEVANCE HEALTH INC FORMERLY","titleOfClass":"COM","cusip":"036752103","value":44357931,"shares":114700,"shareType":"SH","priorValue":33578425,"priorShares":114700},{"issuer":"SHATTUCK LABS INC","titleOfClass":"COM","cusip":"82024L103","value":43764521,"shares":6306127,"shareType":"SH","priorValue":40548397,"priorShares":6306127},{"issuer":"UPSTREAM BIO INC","titleOfClass":"COM","cusip":"91678A107","value":39399636,"shares":5693589,"shareType":"SH","priorValue":51242301,"priorShares":5693589},{"issuer":"CRINETICS PHARMACEUTICALS IN","titleOfClass":"COM","cusip":"22663K107","value":37382580,"shares":999000,"shareType":"SH","priorValue":36283680,"priorShares":999000},{"issuer":"RHYTHM PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"76243J105","value":35851587,"shares":322900,"shareType":"SH","priorValue":27317277,"priorShares":314100},{"issuer":"SYNDAX PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"87164F105","value":33708120,"shares":1542000,"shareType":"SH","priorValue":22479328,"priorShares":962300},{"issuer":"FORTE BIOSCIENCES INC","titleOfClass":"COM NEW","cusip":"34962G208","value":33526231,"shares":1577705,"shareType":"SH","priorValue":31001135,"priorShares":1196955},{"issuer":"COMPASS THERAPEUTICS INC","titleOfClass":"COM","cusip":"20454B104","value":33331787,"shares":15219994,"shareType":"SH","priorValue":80513768,"priorShares":15219994},{"issuer":"NEKTAR THERAPEUTICS","titleOfClass":"COM NEW","cusip":"640268306","value":32485804,"shares":465346,"shareType":"SH","priorValue":19786250,"priorShares":275000},{"issuer":"KRYSTAL BIOTECH INC","titleOfClass":"COM","cusip":"501147102","value":30922944,"shares":83200,"shareType":"SH","priorValue":17849912,"priorShares":69100},{"issuer":"PRELUDE THERAPEUTICS INC","titleOfClass":"NON VOTING","cusip":"000000000","value":30275391,"shares":5680186,"shareType":"SH","priorValue":22079801,"priorShares":6210899},{"issuer":"AXSOME THERAPEUTICS INC.","titleOfClass":"COM","cusip":"05464T104","value":28779567,"shares":117578,"shareType":"SH","priorValue":36156927,"priorShares":213921},{"issuer":"KINIKSA PHARMACEUTICALS INTL","titleOfClass":"ORD SHS CL A","cusip":"G52694109","value":26897370,"shares":420600,"shareType":"SH","priorValue":8695842,"priorShares":180599},{"issuer":"TREVI THERAPEUTICS INC","titleOfClass":"COM","cusip":"89532M101","value":26674964,"shares":1430293,"shareType":"SH","priorValue":29280992,"priorShares":2454400},{"issuer":"ABIVAX SA","titleOfClass":"SPONSORED ADS","cusip":"00370M103","value":26652000,"shares":200000,"shareType":"SH","putCall":"Call"},{"issuer":"DISC MEDICINE INC","titleOfClass":"COM","cusip":"254604101","value":26150110,"shares":357535,"shareType":"SH","priorValue":68259147,"priorShares":1067550},{"issuer":"WEST PHARMACEUTICAL SVSC INC","titleOfClass":"COM","cusip":"955306105","value":25345400,"shares":70600,"shareType":"SH"},{"issuer":"RELMADA THERAPEUTICS INC","titleOfClass":"COM","cusip":"75955J402","value":25127869,"shares":3631195,"shareType":"SH","priorValue":32822413,"priorShares":4715864},{"issuer":"UROGEN PHARMA LTD","titleOfClass":"COM","cusip":"M96088105","value":24883682,"shares":676187,"shareType":"SH","priorValue":15741256,"priorShares":875487},{"issuer":"SUTRO BIOPHARMA INC","titleOfClass":"COM SHS","cusip":"869367201","value":24698941,"shares":743944,"shareType":"SH","priorValue":19956497,"priorShares":801144},{"issuer":"SAVARA INC","titleOfClass":"COM","cusip":"805111101","value":24392984,"shares":3959900,"shareType":"SH","priorValue":3467100,"priorShares":635000},{"issuer":"NEUROPACE INC","titleOfClass":"COM","cusip":"641288105","value":23916436,"shares":1505125,"shareType":"SH","priorValue":27569330,"priorShares":2096527},{"issuer":"AURA BIOSCIENCES INC","titleOfClass":"COM","cusip":"05153U107","value":23666664,"shares":3333333,"shareType":"SH"},{"issuer":"ORIC PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"68622P109","value":21822450,"shares":2015000,"shareType":"SH","priorValue":34132080,"priorShares":2693929},{"issuer":"CYBIN INC","titleOfClass":"COM NEW","cusip":"23256X407","value":21623954,"shares":3271400,"shareType":"SH","priorValue":18397646,"priorShares":3832843},{"issuer":"BIOCRYST PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"09058V103","value":18520000,"shares":1852000,"shareType":"SH","priorValue":13567904,"priorShares":1425200},{"issuer":"BIOAGE LABS INC","titleOfClass":"COM","cusip":"09077V100","value":18435270,"shares":752153,"shareType":"SH","priorValue":12449574,"priorShares":711811},{"issuer":"PROTAGONIST THERAPEUTICS INC","titleOfClass":"COM","cusip":"74366E102","value":18387000,"shares":150000,"shareType":"SH","putCall":"Call"},{"issuer":"LEXEO THERAPEUTICS INC","titleOfClass":"COM","cusip":"52886X107","value":18377242,"shares":3947850,"shareType":"SH","priorValue":20678063,"priorShares":3602450},{"issuer":"WHITEHAWK THERAPEUTICS INC","titleOfClass":"COM","cusip":"00032Q104","value":18019076,"shares":3934296,"shareType":"SH","priorValue":14372700,"priorShares":4166000},{"issuer":"DEFINIUM THERAPEUTICS INC","titleOfClass":"COM SHS","cusip":"24477V105","value":17188416,"shares":365400,"shareType":"SH","priorValue":15195600,"priorShares":804000},{"issuer":"SPYRE THERAPEUTICS INC","titleOfClass":"COM NEW","cusip":"00773J202","value":16525953,"shares":186145,"shareType":"SH"},{"issuer":"CORBUS PHARMACEUTICALS HLDGS","titleOfClass":"COM NEW","cusip":"21833P301","value":16295752,"shares":1737287,"shareType":"SH","priorValue":16313125,"priorShares":1737287},{"issuer":"VERA THERAPEUTICS INC","titleOfClass":"CL A","cusip":"92337R101","value":15859364,"shares":369596,"shareType":"SH","priorValue":14868847,"priorShares":369596},{"issuer":"ALUMIS INC","titleOfClass":"COM","cusip":"022307102","value":15425307,"shares":548163,"shareType":"SH","priorValue":12076031,"priorShares":548163},{"issuer":"EYEPOINT INC","titleOfClass":"COM NEW","cusip":"30233G209","value":15288802,"shares":1069147,"shareType":"SH","priorValue":13781305,"priorShares":1069147},{"issuer":"WATERS CORP","titleOfClass":"COM","cusip":"941848103","value":15114112,"shares":40300,"shareType":"SH"},{"issuer":"MONOPAR THERAPEUTICS INC","titleOfClass":"COM NEW","cusip":"61023L207","value":14575796,"shares":157423,"shareType":"SH"},{"issuer":"TRAVERE THERAPEUTICS INC","titleOfClass":"COM","cusip":"89422G107","value":14372930,"shares":253000,"shareType":"SH"},{"issuer":"TAYSHA GENE THERAPIES INC","titleOfClass":"COM SHS","cusip":"877619106","value":13620000,"shares":2000000,"shareType":"SH"},{"issuer":"BIOGEN INC","titleOfClass":"COM","cusip":"09062X103","value":13309296,"shares":61600,"shareType":"SH","priorValue":11293128,"priorShares":61600},{"issuer":"REVOLUTION MEDICINES INC","titleOfClass":"COM","cusip":"76155X100","value":13203240,"shares":70500,"shareType":"SH","priorValue":5057000,"priorShares":52000},{"issuer":"DIANTHUS THERAPEUTICS INC","titleOfClass":"COM","cusip":"252828108","value":11210200,"shares":115000,"shareType":"SH"},{"issuer":"SPRUCE BIOSCIENCES INC","titleOfClass":"COM NEW","cusip":"85209E208","value":10800000,"shares":200000,"shareType":"SH"},{"issuer":"LIFESTANCE HEALTH GROUP INC","titleOfClass":"COM","cusip":"53228F101","value":10146654,"shares":947400,"shareType":"SH","priorValue":3185000,"priorShares":500000},{"issuer":"REVOLUTION MEDICINES INC","titleOfClass":"COM","cusip":"76155X100","value":9364000,"shares":50000,"shareType":"SH","putCall":"Call"},{"issuer":"ERASCA INC","titleOfClass":"COM","cusip":"29479A108","value":9084888,"shares":495900,"shareType":"SH"},{"issuer":"PROTARA THERAPEUTICS INC","titleOfClass":"COM STK","cusip":"74365U107","value":8480400,"shares":2220000,"shareType":"SH"},{"issuer":"KEROS THERAPEUTICS INC","titleOfClass":"COM","cusip":"492327101","value":8122959,"shares":759155,"shareType":"SH","priorValue":8381071,"priorShares":759155},{"issuer":"JANUX THERAPEUTICS INC","titleOfClass":"COM","cusip":"47103J105","value":8059392,"shares":524700,"shareType":"SH","priorValue":13672040,"priorShares":983600},{"issuer":"TECTONIC THERAPEUTIC INC","titleOfClass":"COM","cusip":"878972108","value":7789375,"shares":226600,"shareType":"SH","priorValue":7004206,"priorShares":226600},{"issuer":"ADICET BIO INC","titleOfClass":"COM NEW","cusip":"007002207","value":7298960,"shares":844787,"shareType":"SH","priorValue":7000299,"priorShares":1027944},{"issuer":"PHARVARIS N V","titleOfClass":"COM","cusip":"N69605108","value":7102732,"shares":205400,"shareType":"SH","priorValue":5802550,"priorShares":205400},{"issuer":"ALTO NEUROSCIENCE INC","titleOfClass":"COM SHS","cusip":"02157Q109","value":6804714,"shares":257852,"shareType":"SH","priorValue":3765400,"priorShares":167500},{"issuer":"ZENTALIS PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"98943L107","value":6744294,"shares":1390576,"shareType":"SH"},{"issuer":"BRIGHT MINDS BIOSCIENCES INC","titleOfClass":"COM NEW","cusip":"10919W405","value":6528600,"shares":93000,"shareType":"SH","priorValue":2918800,"priorShares":40000},{"issuer":"PALVELLA THERAPEUTICS INC NE","titleOfClass":"COM","cusip":"697947109","value":6112800,"shares":40000,"shareType":"SH","putCall":"Call","priorValue":6232500,"priorShares":50000},{"issuer":"ALX ONCOLOGY HLDGS INC","titleOfClass":"COM","cusip":"00166B105","value":5933150,"shares":2866256,"shareType":"SH","priorValue":5746843,"priorShares":2866256},{"issuer":"TRAVERE THERAPEUTICS INC","titleOfClass":"NOTE 0.500% 5/1","cusip":"89422GAB3","value":5894350,"shares":5000000,"shareType":"PRN"},{"issuer":"XILIO THERAPEUTICS INC","titleOfClass":"COM","cusip":"98422T209","value":5674234,"shares":592300,"shareType":"SH"},{"issuer":"BICARA THERAPEUTICS INC","titleOfClass":"COM","cusip":"055477103","value":5673759,"shares":191100,"shareType":"SH","priorValue":13272597,"priorShares":667300},{"issuer":"IMAGENEBIO INC","titleOfClass":"COM","cusip":"45175G207","value":5364687,"shares":909269,"shareType":"SH","priorValue":1892780,"priorShares":378556},{"issuer":"PROTAGONIST THERAPEUTICS INC","titleOfClass":"COM","cusip":"74366E102","value":5160618,"shares":42100,"shareType":"SH","priorValue":4437340,"priorShares":42100},{"issuer":"ALNYLAM PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"02043Q107","value":5117510,"shares":17000,"shareType":"SH","priorValue":39373530,"priorShares":119000},{"issuer":"PALISADE BIO INC","titleOfClass":"COM","cusip":"696389402","value":4875970,"shares":2333000,"shareType":"SH","priorValue":4082750,"priorShares":2333000},{"issuer":"REVOLUTION MEDICINES INC","titleOfClass":"NOTE 0.500% 5/0","cusip":"76155XAA8","value":4379725,"shares":3500000,"shareType":"PRN"},{"issuer":"ATAIBECKLEY INC","titleOfClass":"COM SHS","cusip":"04650F101","value":4202825,"shares":797500,"shareType":"SH","priorValue":1228380,"priorShares":347000},{"issuer":"UNITEDHEALTH GROUP INC","titleOfClass":"COM","cusip":"91324P102","value":4156300,"shares":10000,"shareType":"SH","putCall":"Call"},{"issuer":"PTC THERAPEUTICS INC","titleOfClass":"COM","cusip":"69366J200","value":4005087,"shares":49100,"shareType":"SH","priorValue":3345183,"priorShares":49100},{"issuer":"ARTIVION INC","titleOfClass":"COM","cusip":"228903100","value":3932250,"shares":175000,"shareType":"SH","priorValue":5529620,"priorShares":151000},{"issuer":"ELEVANCE HEALTH INC FORMERLY","titleOfClass":"COM","cusip":"036752103","value":3867300,"shares":10000,"shareType":"SH","putCall":"Call"},{"issuer":"NEUMORA THERAPEUTICS INC.","titleOfClass":"COM","cusip":"640979100","value":3637799,"shares":2139882,"shareType":"SH"},{"issuer":"ACADIA PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"004225108","value":3466100,"shares":137000,"shareType":"SH"},{"issuer":"AMYLYX PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"03237H101","value":3293864,"shares":183400,"shareType":"SH"},{"issuer":"TYRA BIOSCIENCES INC","titleOfClass":"COM","cusip":"90240B106","value":3257880,"shares":102000,"shareType":"SH"},{"issuer":"RAPPORT THERAPEUTICS INC","titleOfClass":"COM","cusip":"75383L102","value":3192589,"shares":76616,"shareType":"SH"},{"issuer":"AGOMAB THERAPEUTICS NV","titleOfClass":"SPONSORED ADS","cusip":"00860C102","value":2501765,"shares":192740,"shareType":"SH"},{"issuer":"TARSUS PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"87650L103","value":2239468,"shares":35581,"shareType":"SH"},{"issuer":"ACLARIS THERAPEUTICS INC","titleOfClass":"COM","cusip":"00461U105","value":2229735,"shares":421500,"shareType":"SH"},{"issuer":"CYTOKINETICS INC","titleOfClass":"COM NEW","cusip":"23282W605","value":2197902,"shares":25800,"shareType":"SH"},{"issuer":"INSPIREMD INC","titleOfClass":"COM","cusip":"45779A846","value":2193697,"shares":3133405,"shareType":"SH","priorValue":5107450,"priorShares":3133405},{"issuer":"OCULAR THERAPEUTIX INC","titleOfClass":"COM","cusip":"67576A100","value":2160400,"shares":220000,"shareType":"SH"},{"issuer":"EVOMMUNE INC","titleOfClass":"COM SHS","cusip":"30054Y107","value":2139690,"shares":161000,"shareType":"SH"},{"issuer":"BELITE BIO INC","titleOfClass":"SPONSORED ADS","cusip":"07782B104","value":2048001,"shares":13300,"shareType":"SH"},{"issuer":"OVID THERAPEUTICS INC","titleOfClass":"COM","cusip":"690469101","value":2009430,"shares":747000,"shareType":"SH"},{"issuer":"EUPRAXIA PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"29842P105","value":1778090,"shares":269000,"shareType":"SH"},{"issuer":"SELLAS LIFE SCIENCES GROUP I","titleOfClass":"COM NEW","cusip":"81642T209","value":1365300,"shares":92500,"shareType":"SH","putCall":"Put"},{"issuer":"COGENT BIOSCIENCES INC","titleOfClass":"NOTE 1.625%11/1","cusip":"19240QAA0","value":1227500,"shares":1000000,"shareType":"PRN","priorValue":1220000,"priorShares":1000000},{"issuer":"VIRIDIAN THERAPEUTICS INC","titleOfClass":"NOTE 1.750% 5/1","cusip":"92790CAB0","value":1072670,"shares":1000000,"shareType":"PRN"},{"issuer":"TRAWS PHARMA INC","titleOfClass":"COM NEW","cusip":"68232V884","value":1014709,"shares":1203260,"shareType":"SH","priorValue":1108122,"priorShares":605531}]},"notice":"Compiled from public SEC Form ADV filings on the dates in `sources`. Facts as filed; not a rating, ranking, or recommendation. Niva Wealth is not affiliated with this firm. Disciplinary history is deliberately not included here or on the page; the SEC publishes the complete record at the `iapdUrl` above."}